Clinical TrialsSearch results
Number of results: 322
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Randomized Phase III Trial of Conventional Paclitaxel and Carboplatin Versus Dose Dense weekly Paclitaxel and Carboplatin in Patients With Newly Diagnosed Stage II-IV Mullerian Carcinoma (Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer)
- Patients with stageII-IV Mullerian Carcinoma (Ovarian Epithelial,Primary Peritoneal,or Fallopian Tube Cancer)
- Japanese Gynecologic Oncology Group
- 2005-09-15
Other
- Randomized Phase III Trial Comparing surgery-alone to UFT+PSK in Stage II Rectal Cancer
- Rectal cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2009-01-01
Other
- Randomized Phase III Trial Comparing Gefitinib with Carboplatin/Paclitaxel in Previously Untreated Advanced Non-Small-Cell Lung Cancer with Epidermal Growth Factor Receptor Gene Mutations
- Advanced Non-Small-Cell Lung Cancer with Epidermal Growth Factor Receptor Gene Mutations
- NEJ Gefitinib Study Group
- 2008-12-31
Other
- Randomized phase III trial comparing adjuvant oral UFT/LV to 5-FU/l-LV in stage III colorectal cancer (JCOG-0205-MF)
- Stage III colorectal cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-09-12
Other
- Randomized phase III study of TS-1 alone versus TS-1 plus Lentinan(LNT) in advanced or recurrent gastric cancer (AGC)
- Advanced or recurrent gastric cancer (AGC)
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2007-01-20
Other
- Randomized phase III study of Standard CHOP(S-CHOP) versus Biweekly CHOP(Bi-CHOP) in aggressive Non-Hodgkin's Lymphoma(JCOG9809)
- Non-Hodgkin's lymphoma
- Japan Clinical Oncology Group(JCOG)
- 2005-08-04
Other
- Randomized Phase III Study of Adjuvant Endocrine-Therapy with or without Chemotherapy for Postmenopausal Breast Cancer Patients who Responded to Neoadjuvant Letrozole
- postmenopausal primary breast cancer
- NEOS executive committee
- 2008-03-20
Other
- Randomized phase III study of 5-FU continuous infusion (5-FUci) versus CPT-11 plus CDDP (CP) versus S-1 alone (S-1) in advanced gastric cancer (JCOG9912)
- advanced or recurrent gastric cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-08-16
Other
- Randomized phase II/III study of R-CHOP versus weekly rituximab plus CHOP for CD20 positive diffuse large B cell lymphoma (JCOG0601)
- CD20 positive diffuse large B cell lmyphoma
- Japan Clinical Oncology Group(JCOG)
- 2007-12-04
Other
- Randomized phase II trial of irinotecan(CPT-11) plus tegafur/uracil with oral leucovorin(UFT/LV) compared with FOLFIRI in patients with unresectable/recurrent colorectal cancer
- Patients with previously untreated and unresectable/recurrent colorectal cancer
- Department of Surgery, School of Medicine, Keio University
- 2007-12-19